• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Karen M. Winkfield, MD, PhD


  • Hoppe BS, Hodgson DC, Advani R, Dabaja BS, Flowers CR, Ha CS, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Terezakis SA, Winkfield KM, Younes A, Constine LS.ACR Appropriateness Criteria: Localized nodal indolent lymphoma.Oncology (Huntingt). 2013 Aug;27(8):786-94.
  • Winkfield KM, Gabeau D.Why workforce diversity in oncology matters.Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):900-1.
  • Nardi V, Winkfield KM, Ok CY, Niemierko A, Kluk MJ, Attar EC, Garcia-Manero G, Wang SA, Hasserjian RP.Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms.J Clin Oncol. 2012 May 14.
  • Winkfield KM, Chen MH, Dosoretz DE, Salenius SA, Katin M, Ross R, D'Amico AV.Race and Survival Following Brachytherapy-based Treatment for Men With Localized or Locally Advanced Adenocarcinoma of the Prostate.Int J Radiat Oncol Biol Phys. 2011 Apr 20.
  • Winkfield KM, Tsai HK, Yao X, Larson E, Neuberg D, Pomeroy SL, Ullrich NJ, Cohen LE, Kieran MW, Scott RM, Goumnerova LC, Marcus KJ.Long-term clinical outcomes following treatment of childhood craniopharyngioma.Pediatr Blood Cancer. 2010 Dec 1.
  • Winkfield KM and Albert MA.Unanswered questions regarding the effect of androgen deprivation therapy for prostate cancer on cardiovascular disease risk in black men.Curr Cardio Risk Rep.;4(4):311-17.
  • Winkfield KM, Harris JR.Effective local therapy and long-term survival in breast cancer.Oncology (Huntingt). 2009 Jul;23(8):669-75.